{
  "ptid_time": "114_S_4404_2019-10-24",
  "img_path": "/data/qiuhui/data/adni/images/114_S_4404/2019-10-24/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 55,868 mm³, 34.3% above the reference mean. With a Z-score of 5.39 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 5,244 mm³, 25.5% below the reference mean. With a Z-score of -14.07 (0.0th percentile), this represents profound atrophy; whole brain volume measures 842,033 mm³, 7.4% below the reference mean. With a Z-score of -0.83 (20.3th percentile), this represents normal volume ; entorhinal cortex volume measures 2,502 mm³, 34.0% below the reference mean. With a Z-score of -3.13 (0.1th percentile), this represents profound atrophy; fusiform gyrus volume measures 13,157 mm³, 10.2% below the reference mean. With a Z-score of -1.28 (10.0th percentile), this represents mild atrophy; middle temporal gyrus volume measures 15,562 mm³, 13.8% below the reference mean. With a Z-score of -7.25 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 90.0 years. Gender is Female. Education: 12 years. MMSE: 21.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.50 SUVR (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows profound atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, middle temporal gyrus) alongside ventricular enlargement, consistent with advanced neurodegeneration. The MMSE score of 21 (moderate impairment) in a 90-year-old female further supports cognitive decline.  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s disease given the pattern of atrophy and elevated AV45 amyloid PET).  \n\n**Confidence:** **High** (severe atrophy in AD-vulnerable regions, low MMSE, and amyloid positivity strongly align with dementia).",
  "timestamp": "2025-07-26T11:47:24.692424"
}